Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:lymphoma incidence/prevalence measurement
go back to main search page
Accession:CMO:0001908 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display lymphomas at a point in time or develop lymphomas within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Lymphoma refers to any of various usually malignant neoplasms of lymphatic and reticuloendothelial tissues that occur as circumscribed solid tumors and that are composed of cells that resemble or originate from lymphocytes, plasma cells, or histiocytes.


show annotations for term's descendants           Sort by:
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        lymphoma incidence/prevalence measurement 0
          T-cell lymphoma incidence/prevalence measurement + 0
Path 2
Term Annotations click to browse term
  clinical measurement 0
    organ measurement 0
      organ lesion measurement 0
        organ tumorous lesion measurement 0
          organ tumorous lesion incidence/prevalence measurement 0
            tumor incidence/prevalence measurement 0
              lymphoma incidence/prevalence measurement 0
                T-cell lymphoma incidence/prevalence measurement + 0
paths to the root